Dr Paul Hiebert's Outputs (2)

A Dual-Acting Nitric Oxide Donor and Phosphodiesterase 5 Inhibitor Promotes Wound Healing in Normal Mice and Mice with Diabetes (2020)
Journal Article
Ben-Yehuda Greenwald, M., Tacconi, C., Jukic, M., Joshi, N., Hiebert, P., Brinckmann, J., Tenor, H., Naef, R., & Werner, S. (2021). A Dual-Acting Nitric Oxide Donor and Phosphodiesterase 5 Inhibitor Promotes Wound Healing in Normal Mice and Mice with Diabetes. Journal of Investigative Dermatology, 141(2), 415-426. https://doi.org/10.1016/j.jid.2020.05.111

Chronic wounds affect a large percentage of the population worldwide and cause significant morbidity. Unfortunately, efficient compounds for the treatment of chronic wounds are yet not available. Endothelial dysfunction, which is at least in part a r... Read More about A Dual-Acting Nitric Oxide Donor and Phosphodiesterase 5 Inhibitor Promotes Wound Healing in Normal Mice and Mice with Diabetes.

Comprehensive characterization of myeloid cells during wound healing in healthy and healing-impaired diabetic mice (2020)
Journal Article
Joshi, N., Pohlmeier, L., Ben-Yehuda Greenwald, M., Haertel, E., Hiebert, P., Kopf, M., & Werner, S. (2020). Comprehensive characterization of myeloid cells during wound healing in healthy and healing-impaired diabetic mice. European journal of immunology, 50(9), 1335-1349. https://doi.org/10.1002/eji.201948438

Wound healing involves the concerted action of various lymphoid and in particular myeloid cell populations. To characterize and quantitate different types of myeloid cells and to obtain information on their kinetics during wound healing, we performed... Read More about Comprehensive characterization of myeloid cells during wound healing in healthy and healing-impaired diabetic mice.